New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Scopely Raises $200M in Strategic Financing to Expand Portfolio Through Acquisitions and Investments
-
NEA Promotes Ed Mathers to General Partner and Blake Wu to Partner
-
OmniSci Announces OEM Startup Accelerator Program For Data-Focused Early Stage Companies
-
OmniSci Announces Version 5.0, Featuring New Capabilities for Accelerated Analytics and Data Science at Massive Scale
-
Databricks’ Growth Draws $400 Million Series F Investment and $6.2 Billion Valuation
-
OmniSci and Intel Collaborate to Bring Accelerated Analytics at Scale to CPUs
-
StreamSets and Databricks Joint Solution Leverages the Power of DataOps to Accelerate ETL and Machine Learning
-
Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
-
IonQ Secures $55 Million in Funding to Bring Quantum Computing from the Lab to the Enterprise
-
IonQ Secures $55 Million in Funding to Bring Quantum Computing from the Lab to the Enterprise
-
OmniSci Debuts 'OmniSci for Good,' Making Accelerated Analytics Accessible for Social Benefit
-
Instabase Raises $105M to Reimagine Business Applications From the Ground Up
-
StreamSets Ranks Among Fastest-Growing Private Companies in Bay Area by San Francisco Business Times
-
Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Startup headed by ex-Apple engineer aims to eliminate smartphone buttons
-
EVERFI CEO Tom Davidson Honored by Goldman Sachs for Entrepreneurship
-
MicroStrategy Partners with DataRobot to Set New Standards for Enterprise AI-Driven Insights
-
OrphoMed to Present at the 2019 BIO Investor Forum
-
McKesson and Aetion Collaborate to Advance Cancer Research With Real-World Data
-
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
-
Stanley, Black & Decker Selects DataRobot to Supersize Data Science Efforts
-
AWIP Launches New York City Chapter to Bridge the Gender Leadership Gap in Tech
-
Fifteen Neurotechnology Startups to Present at 2019 Neurotech Leaders Forum in San Francisco
-
Fugue Adopts Open Policy Agent (OPA) for its Policy-as-Code Framework for Cloud Security
-
Duolingo Names Gillian Munson to Board of Directors
-
Korro Bio Launched to Advance Groundbreaking New Approach to Nucleic Acid Editing
-
Solera Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
-
Marquee TV Selects ViewLift to Power New OTT Content Platform
-
Coursera Launches Coursera for Campus to Help Universities Around the World Take a Digital Leap
-
Tyto Care Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
-
LetsGetChecked Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
-
CarePredict Ranked Among the Most Promising Digital Health Startups in the CB Insights' Digital Health 150 List
-
Databricks Partners with Tableau: Enabling Organizations To Run Business Intelligence on Data Lakes Faster and More Reliably
-
Protenus Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
-
Deep Lens, Inc. Named to the 2019 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups
-
ControlRad™ Secures $15 Million Series B Financing, Expands Board of Directors
-
NewLink Genetics (NLNK) and Lumos Pharma Enter Merger Agreement
-
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
-
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
-
DataRobot Enhances Enterprise AI Platform, Further Automating the Path from Data to Value
-
CIT GAP Funds Invests in Fend to Advance Cybersecurity Solutions for Critical Infrastructure
-
Inventiva: H1 2019 financial results and corporate business update
-
Qpex Biopharma to Present its Anti-infective Portfolio at IDWeek 2019
-
Sentry Raises $40 Million Series C to Reinvent Application Performance Monitoring (APM)
-
PatientPing Drives Better Healthcare with a Healthy Database
-
Topia and Schneider Electric Win Bronze in Brandon Hall Group's Human Capital Management Excellence Awards
-
CIT Announces Annual Funding Sources Series for FY2020
-
Former FDA Commissioner Scott Gottlieb Joins Aetion's Board of Directors
-
DataRobot Announces $206 Million Series E Funding Round
-
DataRobot Launches MLOps Solution

